Relationship_NN
between_IN
Rap1_NN
protein_NN
phosphorylation_NN
and_CC
regulation_NN
of_IN
Ca2_NN
+_CC
transport_NN
in_IN
platelets_NNS
:_:
a_DT
new_JJ
approach_NN
._.

Although_IN
the_DT
interrelationship_NN
between_IN
the_DT
two_CD
messengers_NNS
Ca2_NNP
+_NNP
and_CC
cyclic_JJ
AMP_NN
in_IN
platelet_NN
function_NN
is_VBZ
well_RB
documented_VBN
,_,
its_PRP$
mechanism_NN
of_IN
action_NN
still_RB
remains_VBZ
to_TO
be_VB
established_VBN
._.

We_PRP
investigated_VBD
here_RB
the_DT
question_NN
of_IN
the_DT
regulation_NN
of_IN
platelet_NN
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
ATPases_NNS
by_IN
cyclic_JJ
AMP_NN
through_IN
the_DT
phosphorylation_NN
of_IN
the_DT
Rap1_NN
protein_NN
using_VBG
a_DT
pathological_JJ
model_NN
._.

We_PRP
first_RB
found_VBD
experimental_JJ
conditions_NNS
where_WRB
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
transport_NN
by_IN
platelet_NN
membrane_NN
vesicles_NNS
appeared_VBD
to_TO
be_VB
dependent_JJ
on_IN
the_DT
phosphorylation_NN
of_IN
the_DT
Rap1_NN
protein_NN
._.

Then_RB
,_,
we_PRP
studied_VBD
platelets_NNS
of_IN
patients_NNS
with_IN
congestive_JJ
heart_NN
failure_NN
for_IN
their_PRP$
expression_NN
of_IN
the_DT
potential_JJ
97_CD
kDa_NN
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
ATPase_CD
target_NN
of_IN
regulation_NN
through_IN
the_DT
Rap1_NN
protein_NN
as_RB
well_RB
as_IN
the_DT
phosphorylation_NN
of_IN
the_DT
Rap1_NN
protein_NN
using_VBG
the_DT
catalytic_JJ
subunit_NN
of_IN
the_DT
cyclic_JJ
AMP-dependent_JJ
protein_NN
kinase_NN
-LRB-_-LRB-
C._JJ
Sub_NN
._.
-RRB-_-RRB-
._.

In_IN
the_DT
first_JJ
patients_NNS
studied_VBN
,_,
we_PRP
found_VBD
no_DT
significant_JJ
modification_NN
in_IN
the_DT
expression_NN
of_IN
the_DT
97_JJ
kDa_NN
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
ATPase_NN
by_IN
Western_NN
blotting_NN
using_VBG
the_DT
PL\/IM_NN
430_CD
monoclonal_JJ
antibody_NN
which_WDT
specifically_RB
recognized_VBD
this_DT
isoform_NN
._.

In_IN
contrast_NN
,_,
the_DT
Rap1_NN
protein_NN
was_VBD
differentially_RB
phosphorylated_VBN
when_WRB
using_VBG
15_CD
micrograms\/ml_NNS
of_IN
the_DT
C._JJ
Sub_NN
._.

These_DT
results_NNS
allowed_VBD
us_PRP
to_TO
use_VB
these_DT
pathological_JJ
platelets_NNS
to_TO
study_VB
the_DT
relationship_NN
between_IN
the_DT
expression_NN
of_IN
Rap1_NN
protein_NN
and_CC
the_DT
regulation_NN
of_IN
Ca2_NN
+_CC
transport_NN
by_IN
selecting_VBG
a_DT
patient_NN
with_IN
severe_JJ
heart_NN
failure_NN
._.

We_PRP
could_MD
show_VB
a_DT
decrease_NN
in_IN
the_DT
expression_NN
as_RB
well_RB
as_IN
in_IN
the_DT
phosphorylation_NN
of_IN
Rap1_NN
protein_NN
and_CC
demonstrate_VBP
a_DT
lower_JJR
effect_NN
of_IN
C._FW
Sub_FW
._.
on_IN
Ca2_NN
+_CC
transport_NN
._.

Finally_RB
,_,
by_IN
studying_VBG
a_DT
further_JJ
series_NN
of_IN
patients_NNS
,_,
we_PRP
could_MD
confirm_VB
that_IN
the_DT
decrease_NN
in_IN
Rap1_NN
protein_NN
expression_NN
in_IN
heart_NN
failure_NN
,_,
whatever_WDT
its_PRP$
extent_NN
,_,
was_VBD
variable_JJ
,_,
and_CC
could_MD
strictly_RB
correlate_VB
the_DT
expression_NN
of_IN
Rap1_NN
protein_NN
with_IN
the_DT
stimulatory_JJ
effect_NN
of_IN
C._FW
Sub_FW
._.
on_IN
Ca2_NN
+_CC
transport_NN
._.

Besides_IN
the_DT
evidence_NN
for_IN
regulation_NN
of_IN
the_DT
expression_NN
of_IN
the_DT
Rap1_NN
protein_NN
in_IN
platelets_NNS
from_IN
patients_NNS
with_IN
heart_NN
failure_NN
,_,
these_DT
findings_NNS
constitute_VBP
a_DT
new_JJ
approach_NN
in_IN
favor_NN
of_IN
the_DT
regulation_NN
of_IN
platelet_NN
Ca2_NN
+_CC
transport_NN
through_IN
the_DT
phosphorylation_NN
of_IN
the_DT
Rap1_NN
protein_NN
._.

